Specialised ERAS application help for Non-US IMG applicants. Most recent NRMP match rate: 58.5%.
ECFMG certification timeline and WFME school accreditation requirements since 2024
Visa sponsorship: many programs do not offer J-1 or H-1B, sharply reducing eligible program pool
No U.S. clinical experience (USCE); most programs require 6+ months to grant interview
Step 2 CK now primary numerical screen since Step 1 went pass/fail in January 2022
Time gaps between medical school graduation and match attempt raise red flags for PDs
Highest absolute volume; non-U.S. IMGs matched 3,109 IM positions in 2024 — most IMG-friendly specialty by slot count
Highest preferred-specialty match rate for non-U.S. IMGs in 2024; positions exceed IMG demand
Demand far exceeds positions among IMGs; non-U.S. IMGs are secondary fill source behind US seniors/DOs
Lowest match rate for non-U.S. IMGs; effectively closed to most non-citizen IMGs
Growing position supply; visa-sponsoring programs relatively common; good IMG access
What we'll work through with you. Each one anchored in NRMP / PD-survey data.
Score Step 2 CK above 245 before submitting ERAS in September, because since Step 1 went pass/fail in 2022 programs use Step 2 CK as their primary quantitative filter and a score below 240 causes automatic screen-out at the majority of programs.
Complete at least 6 months of USCE (observerships or clinical rotations) before applying, because NRMP PD survey data show USCE is the second most-cited screening factor for IMGs and programs in IM, FM, and psychiatry explicitly list it as a requirement.
Obtain ECFMG certification before the ERAS opening in early July so your application is flagged as complete from day one, because programs routinely filter out incomplete applications during their initial batch review in October.
Apply broadly to 80–120 programs across a primary specialty and one backup specialty (e.g., IM + psychiatry), because the NRMP's contiguous-rank data show matched non-U.S. IMGs ranked a median of 5–7 programs in IM vs. 2 for unmatched; breadth drives placement probability.
Pursue U.S. clinical letters from attending physicians who directly supervised you, because NRMP PD survey 2024 shows 84% of PDs weight specialty-specific LoRs highly and non-U.S. letters are difficult to calibrate relative to U.S. training standards.
Verify visa sponsorship policy for every program before ranking; filtering to J-1 or H-1B-accepting programs first reduces your effective universe but prevents wasted application fees on programs that will not consider you.
Use the NRMP preference signal (available since 2023) on your top 5 programs, because programs report it raises interview yield for signaled applicants and it costs nothing.
Non-U.S. IMGs are effectively excluded from dermatology, orthopedic surgery, plastic surgery, and neurosurgery: ortho match rate is 12.5% and plastic surgery 53.0% among those who apply, but total IMG applicants in these fields are extremely small and virtually no non-citizen IMGs fill positions in derm or plastics. Applicants targeting these fields without a prior U.S. residency or exceptional research portfolios should plan backup specialties.
Most non-U.S. citizen IMG residents train on a J-1 Exchange Visitor visa sponsored by ECFMG; J-1 holders must return to their home country for two years after training unless they obtain a waiver (Conrad 30, FLEX waiver, IHS, or federal agency waiver). H-1B sponsorship is available at some programs but requires separate employer petition; only ~45% of programs accept either J-1 or H-1B. Applicants needing visa sponsorship should filter FREIDA/ERAS program notes and confirm sponsorship policy before ranking.
Non-U.S. IMG personal statements must bridge the geographic and training gap by explicitly connecting home-country clinical experience to U.S. healthcare values and demonstrating awareness of U.S. residency culture. Lead with a specific patient encounter that illustrates your clinical reasoning, then pivot to why the target specialty and the United States are the logical next step — avoid generic 'I have always wanted to help people' openings. Close with a forward-looking paragraph that shows you understand the specialty landscape and the specific demands of post-graduate training, as this reassures PDs you are a realistic and committed applicant.
At least two of three letters must come from U.S.-based physicians who have directly supervised your clinical work, because most IM, FM, and pediatrics PDs explicitly note they weight U.S. letters far more heavily than letters from home-country supervisors. If USCE is limited, a letter from a U.S. researcher or academic physician who knows your work personally is acceptable as a third letter. Avoid generic letters from department chairs who have not worked with you clinically — PDs recognize filler letters immediately.
Caribbean school stigma: PDs associate Big-4 Caribbean schools with a pipeline of attrition; applicants must actively counter the narrative
Read more →2024 dataCompetitive specialty access: dermatology, plastic surgery, and neurosurgery remain MD-dominant even post-single accreditation in 2020
Read more →2024 dataCompetitive specialty application: dermatology, ortho, neurosurgery, and plastic surgery require publication portfolios and sub-internship performances well above the MD senior average
Read more →2024 dataMust explain prior unmatched cycle credibly and without appearing defensive in personal statement and interviews
Read more →Specialised ERAS review that knows your category's competitive context — not a generic template. Pair your application with a reviewer who's matched applicants like you before.
Data sourced from NRMP, ECFMG, AAMC, AACOM. Match year 2024.